Introduction
Marine algae are known to produce a wide variety of bioactive secondary metabolites and several compounds have been derived from them for prospective development of novel drugs by the pharmaceutical industries [1] . Marine macro-algae are considered as the actual producers of some bioactive compounds with high activity [2] . Red algae of family Rhodomelaceae are known as a rich source of bromophenols [3] . Some of these compounds previously isolated from the family exhibited a wide spectrum of pharmacological activities such as cytotoxic, antioxidant, antiinflammatory and antimicrobial activities [4] .
The green algae (Ulva lactuca) have long been used as food and as a traditional medical agent to treat various infections and diseases [5] . The antimicrobial activity of Ulva lactuca was reported to be caused by the acrylic acid, commonly found in the algae [6] . Antibacterial effects of hexane and methanol extracts of the macro-algae (Mastocarpus stellatus) againist pathogenic bacteria were also reported [7] . Antibacterial activity of Ulva reticulata (U. reticulata )from Kanyakumari coast has not been studied for biotechnological applications and biopharmaceuticals. In this context, a study was undertaken to isolate and evaluate the prospective bioactive substances from U. reticulata.
Materials and methods

Collection of seaweed samples
Fresh seaweed samples of U. reticulata were collected from the Kanyakumari coast of India. Healthy and well grown plants were collected and cleaned with seawater and then freshwater to remove all epiphytes and dried in room temperature. The dried samples were powdered for the extraction of antimicrobial compounds.
Extraction of macro-algae
Dried powder of (50 g) seaweed samples was immersed in n-butanol, percolated three times and kept for evaporation. The dried extract powder was dissolved in the respective solvent and used for the bioassay.
A RT I C L E I N F O
A B S T R AC T
Evaluation of antibacterial activity
Antibacterial activity of the U. reticulata was tested using pathogenic bacteria. The pathogens included Salmonella typhi, Staphylococcus aureus, Escherichia coli (E. coli), Pseudomonas aeruginosa, Vibrio cholerae, Vibrio parahaemolyticus, Bacillus cereus (B. cereus) and Listeria monocytogenes. The bacterial strains were grown in nutrient broth medium at 37 °C . Stock cultures were maintained in nutrient medium at 4 °C and sub-cultured at regular intervals. The nutrient agar medium contained 5 g peptone, 3 g beef extract, 5 g NaCl and 20 g agar in distilled water.
Antimicrobial activity was evaluated using the agar diffusion technique in Petri dishes. Briefly, 20 mg evaporated extract was impregnated into a sterile filter paper disc (5 mm diameter). The impregnated extracts and commercial antibiotic disc were placed on seeded agar plates and kept it for incubation. After 24 h of incubation, the zone of inhibition of the bacterial species was measured by using graduated scale and expressed as millimetre in diameter. Discs containing standard concentrations of chloramphenicol were used as controls.
Results
The antibacterial activity of U. reticulata was evaluated against the pathogenic bacterial strains. The antibacterial activity against each bacterial strain was presented in Table 1 . The n-butanolic extract of the seaweed powder of U. reticulata (25-100 mg/mL) exerted notable antibacterial activity against tested bacterial strains. The maximum antibacterial activity was exhibited against E. coli and B. cereus in all concentrations. 
Discussion
The results obtained in the present investigation supported the traditional use of the seaweeds against various infections. The present study revealed that n-butanol has higher efficiency in extracting antibacterial compounds from macro-algae. Pesando and Caram reported that E. coli was more sensitive to Laurencia obtusa [8] . Glombitza suggested that dimethyl sulphide and acrylic acid from seaweeds have antimicrobial activity [9] . Pratt et al. observed that macro-algae were known to reduce typhoid, cholera, dysentery [10] . Literature survey clarified that marine algae are the richest sources of dietary fibre, minerals, proteins and vitamins, and anti-oxidant activity of these seaweeds would elevate their value in the human diet as food and pharmaceutical supplements [11] . To our knowledge, this is the first report from India of bioactive compounds from U. reticulata, which is effective against the multiple drug resistant bacteria.
In conclusion, the results of the present investigation indicated the scope for deriving biologically active compounds from macroalgae which are effective in inhibiting the growth of the pathogenic bacteria Gram-positive and Gram-negative, indicating a great scope for further investigations towards the development of novel drugs.
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